WHO2025EN
Diagnostic testing for Ebola and Marburg virus diseases: interim guidance, 20 December 2024
Zusammenfassung
-1-
Diagnostic testing for Ebola and Marburg virus
diseases
Interim guidance
20 December 2024
Key recommendations
- The goal of diagnostic testing for Ebola and Marburg virus diseases i s to identify cases to provide timely
and appropriate care and to stop disease transmission.
- All individuals meeting the case definition for Ebola or Marburg virus diseases should be tested.
- The recommended sample type for testing for orthoebolaviruses and orthomarburg
Kerninformationen
The viruses belonging to Orthoebolavirus and Orthomarburgvirus genera are single stranded negative sense
RNA viruses within the Filoviridae family. Six Orthoebolavirus species have been characterized to date, with
one virus per species including Bombali virus (BOMV), Bundibugyo virus (BDBV), Resto...
ation according to ICTV, 2024
1
.
Disease caused by infection with an orthoebolavirus may be referred to by the specific disease names as
described above in the table, or by the generic term “Ebola disease” (EBOD). Disease caused by infection with
either of the orthomarburgviruse...
ecific. It is therefore important to
characterize the species and virus causing the outbreak to enable the deployment of appropriate
countermeasures.
Purpose of this document
The scope of this guidance is to provide interim recommendations regarding the diagnosis of EBO...
Fragen zu diesem Thema?
ClariMed durchsucht alle Leitlinien mit KI und liefert quellenbasierte Antworten in Sekunden.
Jetzt auf ClariMed suchenVerwandte Leitlinien
WHO2023
Infection prevention and control guideline for Ebola and Marburg disease, August 2023
WHO2021
Antigen-detection in the diagnosis of SARS-CoV-2 infection: interim guidance, 6 October 2021
WHO2024
Infection prevention and control and water, sanitation and hygiene measures for Crimean-Congo haemorrhagic fever in health-care settings: operational guide
WHO2024
WHO Guidelines on Hepatitis B and C Testing
WHO2025
Clinical management and infection prevention and control for mpox: living guideline, May 2025
IDSA2026
COVID-19 Guideline Part 3: Molecular Diagnostic Testing
IDSA2023
IDSA: COVID-19 Molecular Diagnostic Testing
WHO2019